FundLens

Best Contra Funds

Against-the-herd positioning in out-of-favour sectors and stocks.

Data updated · 4 direct-growth funds ranked by a transparent 0–100 Smart Score

4
Funds
0
Strong Buys
High
Risk
4 funds
⚖Want to compare funds? Tick the checkbox in the first column — pick up to 5 and they'll go head-to-head in one view.
⚖ VSFund Score ↓Verdict1Y 3Y 5Y Sharpe Sortino Std Dev Alpha Beta VR★ P/E Expense AUM Age
Kotak Contra
Kotak
67
Buy4.2%16.3%14.8%0.820.8915.83.80.994★22.90.77%₹5.4k Cr13.7y
Invesco India Contra
Invesco
44
Avoid3.0%15.7%13.9%0.740.8416.12.61.005★28.00.75%₹20.1k Cr13.7y
SBI Contra
SBI
42
Avoid0.5%12.0%16.0%0.730.5514.52.30.902★17.60.84%₹48.3k Cr13.7y
Motilal Oswal Contra
Motilal Oswal
13
Avoid—————————31.8—₹374 Cr0.3y
Reading the ratios: ↑ higher is better — Returns, Sharpe, Sortino, Alpha · ↓ lower is better — Std Dev, P/E, Expense · Beta ≈1 moves with the market (<1 swings less). Hover any column header for details.

Contra funds — quick answers

›Which is the best Contra mutual fund right now?

Kotak Contra currently ranks #1 of 4 Contra funds with a FundLens Smart Score of 67/100 (Buy). It returned 16.3% over 3 years and 14.8% over 5 years at a 0.77% expense ratio (direct plan). Rankings are recomputed from data updated 03 Sept 2026.

›Which Contra fund has the best risk-adjusted returns?

Kotak Contra leads the category on the Sortino ratio at 0.89 (Sharpe 0.82) — meaning it has delivered the most return per unit of downside risk among Contra funds.

›Which Contra fund has the lowest expense ratio?

Invesco India Contra charges 0.75% a year (direct plan) — the lowest in the category. Lower fees compound in your favour over long holding periods.

›Which is the smallest Contra fund by AUM?

Motilal Oswal Contra manages ₹374 Cr, the smallest in the category. Smaller funds can be nimbler, but check track record and costs before treating size alone as an edge.

›How long should I stay invested in a Contra fund?

Contra funds carry high risk, so a horizon of 5+ years is generally sensible. Against-the-herd positioning in out-of-favour sectors and stocks. This is research, not investment advice.

Want these answers conversationally? Ask FundLens · New to the ratios? Sharpe vs Sortino, explained